Abstract
The completion of the Human Genome Project and the ongoing sequencing of mouse, rat, and other genomes have led to an explosion of genetics-related technologies that are finding their way into all areas of biological research in both basic sciences and clinical applications. High-throughput genomics and proteomics technology has been quickly adapted to develop tools for clinical and pharmacological applications. Because molecular alterations usually occur much earlier than histological, physiological, and clinical abnormality, researchers hope to extend the applications of genomics and/or proteomics technology to early diagnosis of diseases and clinical outcome prognosis. Recently, some successful attempts in molecular diagnosis or prognosis have been published. However, for such tests to be translated from the bench to the bed, they must meet some rigorous standards. To develop a clinically meaningful genomics-based diagnostic test, we must have good study design, appropriate statistical analyses, and valid assessment of its clinical efficacy. In this chapter, we discuss statistical considerations on the process of developing reliable and useful genomics- or proteomics-based tests.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Collins, F. S., Green, E. D., Guttmacher, A. E., and Guyer, M. S. (2003) A vision for the future of genomics research. Nature 422, 835–847.
Golub, T. R., Slonim, D. K., Tamayo, P., et al. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286, 531–537.
Alizadeh, A. A., Eisen, M. B., Davis, R. E., et al. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503–511.
Bittner, M., Meltzer, P., Chen, Y., et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536–540.
Perou, C. M., Sorlie, T., Eisen, M. B., et al. (2000) Molecular portraits of human breast tumors. Nature 406, 747–752.
You, S. A., Archacki, S. R., Angheloiu, G., et al. (2003) Proteomic approach to coronary atherosclerosis shows ferritin light chain as a significant marker, evidence consistent with iron hypothesis in atherosclerosis. Physiol. Genomics 13, 25–30.
Bullinger, L., Dohner, K., Bair, E., et al. (2004) Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N. Engl. J. Med. 350, 1605–1616.
Dave, S. S., Wright, G., Tan, B., et al. (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N. Engl. J. Med. 351, 2159–2169.
Holleman, A., Cheok, M. H., den Boer, M. L., et al. (2004) Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment. N. Engl. J. Med. 351, 533–542.
Lossos, I. S., Czerwinski, D. K., Alizadeh, A. A., et al. (2004) Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N. Engl. J. Med. 350, 1828–1837.
Rassenti, L. Z., Huynh, L., Toy, T. L., et al. (2004) ZAP-70 Compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. N. Engl. J. Med. 351, 893–901.
Sarwal, M., Chua, M. S., Kambham, N., et al. (2003) Molecular heterogeneity in acute renal allograft rejection identified by DNA microarray profiling. N. Engl. J. Med. 349, 125–138.
Chang, J. C., Wooten, E. C., Tsimelzon, A., et al. (2003) Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. Lancet 362, 362–369.
Bueno, R., Loughlin, K. R., Powell, M. H., and Gordon, G. J. (2003) A diagnostic test for prostate cancer from gene expression profiling data. J. Urol. 171, 903–906.
Guttmacher, A. E. and Collins, F. S. (2002) Genomic medicine—a primer. N. Engl. J. Med. 347, 1512–1520.
Burke, W. (2002) Genomic medicine: genetic testing. N. Engl. J. Med. 347, 1867–1875.
Khoury, M. J., McCabe, L. L., and McCabe, E. R. B. (2003) Genomic medicine: population screening in the age of genomic medicine. N. Engl. J. Med. 348, 50–58.
Goldstein, D. B. (2003) Pharmacogenetics in the laboratory and the clinic. N. Engl. J. Med. 348, 553–556.
Evans, W. E. and McLeod, H. L. (2003) Drug therapy: pharmacogenomics—drug disposition, drug targets, and side effects. N. Engl. J. Med. 348, 538–549.
Weinshilboum, R. (2003) Genomic medicine: inheritance and drug response. N. Engl. J. Med 348, 529–537.
Lynch, H. T. and de la Chapelle, A. (2003) Genomic medicine: hereditary colorectal cancer. N. Engl. J. Med. 348, 919–932.
Nussbaum, R. L. and Ellis, C. E. (2003) Genomic medicine: Alzheimer’s disease and Parkinson’s disease. N. Engl. J. Med. 348, 1356–1364.
Staudt, L. M. (2003) Genomic medicine: molecular diagnosis of the hematologic cancers. N. Engl. J. Med. 348, 1777–1785.
Wooster, R. and Weber, B. L. (2003) Genomic medicine: breast and ovarian cancer. N. Engl. J. Med. 348, 2339–2347.
Nabel, E. G. (2003) Genomic medicine: cardiovascular disease. N. Engl. J. Med. 349, 60–72.
Burke, W. (2003) Genomic medicine: genomics as a probe for disease biology. N. Engl. J. Med. 349, 969–974.
Guttmacher, A. E., Collins, F. S., and Carmona, R. H. (2004) The family history—more important than ever. N. Engl. J. Med. 351, 2333–2336.
Ansell, S. M., Ackerman, M. J., Black, J. L., Roberts, L. R., and Tefferi, A. (2003) A Primer on medical genomics. Part VI, Genomics and molecular genetics in clinical practice. Mayo Clin. Proc. 78, 307–317.
Sackett, D. L., Rosenberg, W. M., Gray, J. A., Haynes, R. B., and Richardson, W. S. (1996) Evidence-based medicine, what it is and what it isn’t. Br. Med. J. 312, 71, 72.
Sox, Jr., H. C., Blatt, M. A., Higgins, M. C., and Marton, K. I. (1989) Med. Decis. Making. Butterworths-Heinemann, Boston, MA.
McNeil, B. J. and Adelstein, S. J. (1976) Determining the value of diagnostic and screening tests. J. Nucl. Med. 17, 439–448.
Zhou, X. H., Obuchowski, N. A., and McClish, D. K. (2002) Statistical Methods in Diagnostic Medicine. John Wiley and Sons, New York, NY.
Metz, C. E. (1989) Some practical issues of experimental design and data analysis in radiological ROC studies. Invest. Radiol. 24, 234–245.
Hastie, T., Tibshirani, R., and Friedman, J. (2001) The Elements of Statistical Learning, Data Mining, Inference, and Prediction. Springer-Verlag, New York, NY.
Fryback, D. G. and Thornbury, J. R. (1991) The efficacy of diagnostic imaging. Med. Decis. Making 11, 88–94.
Tan, P. K., Downey, T. J., Spitznagel, Jr., E. L., et al. (2003) Evaluation of gene expression measurements from commercial microarray platforms. Nucleic Acids Res. 31, 5676–5684.
Woo, Y., Affourtit, J., Daigle, S., et al. (2004) A comparison of cDNA, oligonucleotide, and Affymetrix GeneChip gene expression microarray platforms. J. Biomol. Tech. 15, 276–284.
Bammler, T., Beyer, R. P., Bhattacharya, S., et al. (2005) Standardizing global gene expression analysis between laboratories and across platforms. Nat. Methods 2, 351–356.
Larkin, J. E., Frank, B. C., Gavras, H., Sultana, R., and Quackenbush, J. (2005) Independence and reproducibility across microarray platforms. Nat. Methods 2, 337–344.
Irizarry, R. A., Warren, D., Spencer, F., et al. (2005) Multiple-laboratory comparison of microarray platforms. Nat. Methods 2, 345–350.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Peng, X. (2006). Developing and Evaluating Genomics- or Proteomics-Based Diagnostic Tests. In: Wang, Q.K. (eds) Cardiovascular Disease. Methods in Molecular Medicine, vol 129. Humana Press. https://doi.org/10.1385/1-59745-213-0:27
Download citation
DOI: https://doi.org/10.1385/1-59745-213-0:27
Publisher Name: Humana Press
Print ISBN: 978-1-58829-892-8
Online ISBN: 978-1-59745-213-7
eBook Packages: Springer Protocols